David Pascoe

David Pascoe started the Rosacea Support Group in October 1998.

Soolantra launches as Rosiver in Canada

Soolantra launches as Rosiver in Canada

Continuing its tradition of launching new prescription products with names unique to Canada, Galderma Canada has announced that the Ivermectin based treatment known as Soolantra in the US will be known as Rosiver in Canada. In Canada, Mirvaso is known as ONRELTEA, and Oracea is known as Apprilon. The full product monograph, including the consumer notes […]

Continue Reading

Vitamin B12 may lead to Acne for some – link found

Written by on July 8, 2015 in Acne Treatments, Rosacea Supplements with 1 Comment
Vitamin B12 may lead to Acne for some – link found

 An interesting finding for those considering Vitamin B12 supplements. A recent study has identified the link responsible in some individuals with taking B12 and developing acne. The study identifies “one molecular explanation for the long-standing clinical observation that vitamin B12 supplementation leads to acne development in a subset of individuals”. Although the link between skin […]

Continue Reading

3% Topical Tranexamic Acid Helps Rosacea (Lysine)

Written by on June 28, 2015 in Rosacea Topicals, What Causes Rosacea? with 0 Comments
3% Topical Tranexamic Acid Helps Rosacea (Lysine)

This article details some modest benefits to rosacea symptoms experienced by users of 3% topical tranexamic acid. Trialists of the active topical experienced an improvement in stratum corneum function and in “clinical signs and symptoms of rosacea”. The authors further detail a suggested pathway of how tranexaminc acid benfits rosacea. See the full text link […]

Continue Reading

Compensatory Flushing with Mirvaso: JAMA Dermatology

Written by on June 24, 2015 in Mirvaso Gel (Brimonidine 0.33%) with 1 Comment
Compensatory Flushing with Mirvaso: JAMA Dermatology

LEFT: Patient at initial clinic visit after 7 months of brimonidine treatment showing compensatory vasodilation and flushing in untreated areas of right lateral cheek and chest. RIGHT: Patient 1 week after cessation of brimonidine treatment showing marked improvement in compensatory vasodilation and flushing. A brief observation published in the Journal of American Medical Association Dermatology […]

Continue Reading

Promius files NDA for modified release tetracycline DFD-09

Promius Pharma, a subsidiary of Dr. Reddy’s Laboratory has filed a New Drug Application for a modified release tetracycline for the treatment of rosacea. Promius is calling their new drug DFD-09. Promius Pharma is probably best know to rosacea sufferers via the availability of Promiseb Topical Cream in the US. Promiseb, a treatment for seborrheic […]

Continue Reading

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.